Effects of insulin-like growth factor I (IGF-I) and insulin on glucose and
potassium fluxes were examined by measuring transhepatic glucose and potass
ium balance in isolated perfused rat livers. At 1 nM, both IGF-I and insuli
n decreased basal glucose release by approximate to 64% (P < 0.05). Adrenal
ine (epinephrine)stimulated glucose release (42.6 +/- 4.5 mu mol/g of liver
within 30 min) was inhibited (P < 0.05) by approximate to 32 and approxima
te to 52% during IGF-I and insulin exposure, which was accompanied by reduc
ed cAMP release(-71 and -80%, P < 0.05). IGF-I- and insulin-induced reducti
on of glucose release only decreased during calcium-free perfusion, but not
during inhibition of phosphoinositide 3-kinase by wortmannin. Both IGF-I a
nd insulin induced net potassium uptake, while insulin also attenuated the
response to adrenaline. In conclusion, IGF-I causes (i) insulinlike inhibit
ion of hepatic glycogenolysis, even at low, nanomolar concentrations, which
is associated with decreased cAMP release, reduced in the absence of Ca2+,
but not mediated by phosphoinositide 3-kinase, (ii) reduction of adrenalin
e-induced glycogenolysis and (iii) net potassium uptake under basal conditi
ons.